Mezym

Pancreas Powder, the active ingredient in Mezym, is a digestive enzyme presented as a pancreatic enzyme preparation for oral use. It facilitates the digestion of fats, proteins, and carbohydrates in patients with exocrine pancreatic insufficiency, including those with cystic fibrosis or post‑surgical pancreatic loss. GNH USA supplies Mezym as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mezym provides pancreatic enzyme replacement therapy for conditions affecting exocrine pancreatic function. - Exocrine pancreatic insufficiency: improves nutrient absorption and reduces steatorrhea. - Cystic fibrosis‑related pancreatic insufficiency: supports digestion and growth in affected individuals. - Post‑pancreatic resection insufficiency: aids digestion after surgical removal of pancreatic tissue.

Pancreatic enzyme replacement can be associated with a range of adverse reactions.

Common Side Effects: - Abdominal discomfort or cramping. - Flatulence or bloating. - Diarrhea or loose stools. - Nausea or mild vomiting. - Constipation. - Unpleasant taste or oral irritation.

Serious or Rare Side Effects: - Allergic reactions such as rash, itching, or swelling. - Severe abdominal pain indicating possible pancreatitis. - Intestinal obstruction or ileus. - Necrotizing colitis. - Anaphylaxis (rare).

When prescribing Mezym, consider the following precautions to ensure safe use. - Dose adjustment: tailor the enzyme dose to the individual’s clinical response and nutritional needs. - Renal impairment: monitor patients with reduced kidney function for accumulation of enzyme fragments. - Allergic history: assess for known hypersensitivity to porcine or bovine pancreatic extracts. - Concomitant antacids: be aware that some antacids may reduce enzyme activity; timing of administration may need adjustment. - Nutritional monitoring: regularly evaluate weight, vitamin levels, and stool fat content. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Pancreatic enzyme preparations can interact with other oral medications, affecting their absorption or activity.

Major Interactions (Avoid): - Bile acid sequestrants (e.g., cholestyramine): may bind enzymes and reduce efficacy. - High‑dose proton pump inhibitors: can alter gastric pH and affect enzyme activation, requiring dose reassessment.

Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium: may interfere with enzyme activity; separate dosing by at least 30 minutes. - Oral contraceptives: theoretical reduction in absorption; monitor for efficacy. - Antibiotics with poor oral absorption (e.g., tetracycline): may have reduced bioavailability when taken with enzymes.